{"drugs":["Technetium Tc 99m Red Blood Cells","Ultratag Rbc"],"mono":{"0":{"id":"924420-s-0","title":"Generic Names","mono":"Technetium Tc 99m Red Blood Cells"},"1":{"id":"924420-s-1","title":"Dosing and Indications","sub":{"0":{"id":"924420-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Cardiac blood pool imaging:<\/b> 370 to 740 megabecquerels (10 to 20 millicuries) IV<\/li><li><b>Isotope study for gastrointestinal blood loss:<\/b> 370 to 740 megabecquerels (10 to 20 millicuries) IV<\/li><\/ul>"},"1":{"id":"924420-s-1-5","title":"Pediatric Dosing","mono":"safety and efficacy have not been established in children "},"3":{"id":"924420-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Cardiac blood pool imaging<\/li><li>Isotope study for gastrointestinal blood loss<\/li><\/ul>"}}},"3":{"id":"924420-s-3","title":"Contraindications\/Warnings","sub":[{"id":"924420-s-3-9","title":"Contraindications","mono":"specific contraindications have not been determined <br\/>"},{"id":"924420-s-3-10","title":"Precautions","mono":"<ul><li>blood borne pathogen transmission potential; implement procedures to avoid administration errors and vial contamination of personnel<\/li><li>radiopharmaceutical; handle with care and use safety measures to reduce radiation exposure to personnel and patient<\/li><li>labeled red blood cells should be administered within 30 minutes of preparation or as soon as possible<\/li><\/ul>"},{"id":"924420-s-3-11","title":"Pregnancy Category","mono":"<ul><li>C (FDA)<\/li><li>C (AUS)<\/li><\/ul>"},{"id":"924420-s-3-12","title":"Breast Feeding","mono":"<ul><li>AAP: Radioactive compounds that require temporary cessation of breastfeeding.<\/li><li>Micromedex: Infant risk cannot be ruled out.<\/li><\/ul>"}]},"5":{"id":"924420-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Other:<\/b>Absence of drug reaction<br\/>"},"6":{"id":"924420-s-6","title":"Drug Name Info","sub":{"0":{"id":"924420-s-6-17","title":"US Trade Names","mono":"Ultratag Rbc<br\/>"},"2":{"id":"924420-s-6-19","title":"Class","mono":"Diagnostic Agent, Radiopharmaceutical Imaging<br\/>"},"3":{"id":"924420-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"}}},"7":{"id":"924420-s-7","title":"Mechanism Of Action","mono":"Technetium Tc 99m red blood cells distributes into the blood pool thereby enabling radiographic imaging <br\/>"},"8":{"id":"924420-s-8","title":"Pharmacokinetics","sub":{"1":{"id":"924420-s-8-24","title":"Distribution","mono":"Vd: 5.6% of body weight<br\/>"},"3":{"id":"924420-s-8-26","title":"Excretion","mono":"Renal: 25% within the first 24 hours<br\/>"},"4":{"id":"924420-s-8-27","title":"Elimination Half Life","mono":"6.02 hours <br\/>"}}},"9":{"id":"924420-s-9","title":"Administration","mono":"<b>Injection, intravenous<\/b><br\/><ul><li>use proper procedures for handling and disposal of radiopharmaceuticals<\/li><li>maintain appropriate shielding throughout the preparation process and for the life of the compound to minimize radiation exposure<\/li><li>wear waterproof gloves during the handling procedure<\/li><li>heparin or Anticoagulant Citrate Dextrose Solution (ACD) should be used for anticoagulation; do not use EDTA Oxalate<\/li><li>add 1 to 3 mL of anticoagulated whole blood to the reaction vial; allow to react for 5 minutes; add contents of Syringe I, mix gently by inverting 4 to 5 times then add contents of Syringe II to the reaction vial and mix gently inverting 4 to 5 times<\/li><li>add 370 to 3700 megabecquerels (10 to 100 millicuries) sodium pertechnetate Tc 99m to the reaction vial; allow to react for 20 minutes.<\/li><li>use largest bore needle compatible with patient administration to prevent hemolysis<\/li><li>measure dose with a suitable radioactivity calibration system just prior to administration<\/li><li>technetium Tc 99m labeled red blood cells should be injected within 30 minutes of preparation<\/li><\/ul>"},"10":{"id":"924420-s-10","title":"Monitoring","mono":"visualization for blood pool imaging indicates efficacy<br\/>"}}}